In addition, miR-22-3p can also act on Sox9 protein, which can regulate the differentiation of astrocyte and the expression of neural stem, through NF-κB signaling pathway to reduce the abnormal aggregation of Aβ and improve the symptoms of AD [125]. The gene discussed is NFKB1; the disease is Alzheimer disease.